Variant report
Variant | nsv971307 |
---|---|
Chromosome Location | chr8:48996181-48998139 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:48984328..48988098-chr8:48992508..48996504,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557667165 | chr8:48996185-48996186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575944995 | chr8:48996259-48996260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs569081531 | chr8:48996278-48996279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs58816127 | chr8:48996302-48996303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs555548701 | chr8:48996327-48996328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573608351 | chr8:48996364-48996365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75293429 | chr8:48996434-48996435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185031905 | chr8:48996453-48996454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577889347 | chr8:48996454-48996455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544929029 | chr8:48996491-48996492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs201154824 | chr8:48996582-48996583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371109128 | chr8:48996590-48996591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs200435805 | chr8:48996603-48996604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563225022 | chr8:48996616-48996617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112772806 | chr8:48996626-48996627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147338232 | chr8:48996627-48996628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561434660 | chr8:48996667-48996668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528546171 | chr8:48996672-48996673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546997198 | chr8:48996740-48996741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567280521 | chr8:48996765-48996766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532537563 | chr8:48996845-48996846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551336998 | chr8:48996849-48996850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371481766 | chr8:48996950-48996951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115547103 | chr8:48996952-48996953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114376815 | chr8:48996975-48996976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374447616 | chr8:48997046-48997047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371909639 | chr8:48997090-48997091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554824893 | chr8:48997123-48997124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs137893095 | chr8:48997126-48997127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373616113 | chr8:48997138-48997139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368633030 | chr8:48997167-48997168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534390931 | chr8:48997269-48997270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs149466001 | chr8:48997300-48997301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189876578 | chr8:48997301-48997302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181082067 | chr8:48997353-48997354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556880624 | chr8:48997363-48997364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575147084 | chr8:48997407-48997408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143939722 | chr8:48997411-48997412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560629202 | chr8:48997505-48997506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528269715 | chr8:48997517-48997518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540408519 | chr8:48997534-48997535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148630086 | chr8:48997535-48997536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142119712 | chr8:48997591-48997592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs550947774 | chr8:48997608-48997609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370861710 | chr8:48997671-48997672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372737268 | chr8:48997737-48997738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375118618 | chr8:48997741-48997742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553271715 | chr8:48997767-48997768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112079868 | chr8:48997790-48997791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377104183 | chr8:48997798-48997799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
22q11 deletion syndrome | 20357662 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Gastric cancer | 22014070 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:48994400-48996200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:48995400-48996400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr8:48996200-48998800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr8:48997400-48997600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr8:48997400-48997600 | Enhancers | NHDF-Ad | bronchial |